Anebulo Pharmaceuticals Aktie - ANEB

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

1,54

Gebot

1,22

Fragen

1,62

Volumen

18.618

1,45 Tagesbereich 1,5877

0,8001 52-Wochen-Bereich 3,30

Marktkapitalisierung

39,937M

Handelsende

1,58

Handelsbeginn

1,57

Letzte Trade

107

1.54

Letzter Handelszeitpunkt

Finanzvolumen

US$ 27.609

VWAP

1,4829

Durchschnittliches Volumen (3 Mio.)

30.515

Ausgegebene Aktien

25.933.217

Dividendenrendite

Kurs-Gewinn-Verhältnis

-4,58

Gewinn pro Aktie (EPS)

-0,32

Erlöse

Nettogewinn

-8,2M

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Mehr anzeigen

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.anebulo.com

Hauptsitz

Dover, Delaware, USA

Gegründet

Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was US$1,58. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of US$ 0,8001 to US$ 3,30.

Anebulo Pharmaceuticals currently has 25.933.217 shares in issue. The market capitalisation of Anebulo Pharmaceuticals is US$40,97 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.58.

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.15	-8.87573964497	1.69	1.69	1.45	9926	1.64673837	CS
4	-0.23	-12.9943502825	1.77	1.8	1.45	30132	1.63819536	CS
12	-0.3	-16.3043478261	1.84	1.95	0.8001	30515	1.40387932	CS
26	-0.66	-30	2.2	3.08	0.8001	17135	1.58331614	CS
52	-0.91	-37.1428571429	2.45	3.3	0.8001	11718	1.85979529	CS
156	-5.07	-76.7019667171	6.61	7.885	0.8001	10311	2.78713925	CS
260	-5.84	-79.1327913279	7.38	9.33	0.8001	11156	3.90964672	CS

ANEB - Frequently Asked Questions (FAQ)

What is the current Anebulo Pharmaceuticals share price?

The current share price of Anebulo Pharmaceuticals is US$ 1,54

How many Anebulo Pharmaceuticals shares are in issue?

Anebulo Pharmaceuticals has 25.933.217 shares in issue

What is the market cap of Anebulo Pharmaceuticals?

The market capitalisation of Anebulo Pharmaceuticals is USD 40,97M

What is the 1 year trading range for Anebulo Pharmaceuticals share price?

Anebulo Pharmaceuticals has traded in the range of US$ 0,8001 to US$ 3,30 during the past year

What is the PE ratio of Anebulo Pharmaceuticals?

The price to earnings ratio of Anebulo Pharmaceuticals is -4,58

What is the reporting currency for Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals reports financial results in USD

What is the latest annual profit for Anebulo Pharmaceuticals?

The latest annual profit of Anebulo Pharmaceuticals is USD -8,2M

What is the registered address of Anebulo Pharmaceuticals?

The registered address for Anebulo Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904

What is the Anebulo Pharmaceuticals website address?

The website address for Anebulo Pharmaceuticals is www.anebulo.com

Which industry sector does Anebulo Pharmaceuticals operate in?

Anebulo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
EVAXEvaxion Biotech AS	US$ 5,99 (64,56%)	55,41M
ELABPMGC Holdings Inc	US$ 3,0901 (56,07%)	76,48M
PCLAPicoCELA Inc	US$ 4,60 (49,35%)	3,75M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
GODNUGolden Star Acquisition Corporation	US$ 3,11 (-75,82%)	17,51k
GODNGolden Star Acquisition Corporation	US$ 2,93 (-65,67%)	902,76k
NXTTNext Technology Holding Inc	US$ 1,37 (-54,93%)	2,56M
SGLYSingularity Future Technology Ltd	US$ 1,625 (-38,45%)	917,77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90,11 (-38,07%)	8
ACONAclarion Inc	US$ 0,0557 (28,94%)	811,91M
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
RIMEAlgorhythm Holdings Inc	US$ 0,0357 (4,69%)	284,97M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
NVDANVIDIA Corporation	US$ 142,62 (-3,12%)	232,88M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Anebulo Pharmaceuticals Inc (ANEB) Börsenkurse

Anebulo Pharmaceuticals Inc (ANEB)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Über Anebulo Pharmaceuticals Inc

ANEB Neueste Nachrichten

ANEB - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen